P Vodvářka

Phase III Study of Gefitinib Compared With Intravenous Methotrexate for Recurrent Squamous Cell Carcinoma of the Head and Neck

J.S.W. Stewart, Ezra E.W. Cohen, Lisa Licitra et al. · Journal of Clinical Oncology · 2009 · 380 citations

Medicine, Oncology, Pharmacology +10

First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study

Olavo Feher, P Vodvářka, Jacek Jassem et al. · Annals of Oncology · 2005 · 93 citations

Medicine, Oncology, Pharmacology +12

Phase III Trial Comparing Granulocyte Colony-Stimulating Factor to Leridistim in the Prevention of Neutropenic Complications in Breast Cancer Patients Treated with Docetaxel/Doxorubicin/Cyclophosphamide: Results of the BCIRG 004 Trial

Jean-Marc A. Nabholtz, Jacques Cantin, José Chang et al. · Clinical Breast Cancer · 2002 · 51 citations

Medicine, Oncology, Pharmacology +15

Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours

Zdeněk Sedláček, Roman Kodet, E Seemanová et al. · British Journal of Cancer · 1998 · 50 citations

Life Sciences, Genetics, Molecular Genetics +16

Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines

Miguel Martín, M. Spielmann, M Namer et al. · Annals of Oncology · 2003 · 47 citations · Full text

Medicine, Oncology, Pharmacology +12